Skip to main content

Stanford’s Laboratory for Cell and Gene Medicine aims to ‘cure the incurable’

laboratory for cell gene medicine braincancer
Creative Commons
When you read about initiatives like Stanford University’s new Laboratory for Cell and Gene Medicine, it’s difficult to think of too many other places on Earth where more exciting — and potentially life-changing — work is being done.

Opened in September, the 25,000-square-foot facility is currently attacking a number of the world’s most challenging medical problems. As laboratory director Dr. David DiGiusto puts it, it’s all about “curing the incurable.”

Recommended Videos

“Many diseases cannot be cured with conventional therapies that are palliative only in nature,” laboratory director DiGiusto told Digital Trends. “Other diseases have no effective treatments at all. Our mission is to develop and test cures for incurable diseases using cell and gene therapy. We are currently working on cancer, monogenic disease (i.e., SCID, sickle cell, and other immune deficiencies), and regenerative medicine [like] dermatology, neurosciences, and cardiovascular medicine.”

Image used with permission by copyright holder

The lab is currently carrying out a range of exciting projects in its “clean rooms.” These include sheets of genetically corrected skin that can be given as skin grafts to patients suffering from the blistering skin disease epidermolysis bullosa, in which layers of skin don’t adhere properly to the body. There are also projects to regenerate corneal cells in the eye, repair mutations in blood cells, genetically engineer immune system T cells to fight cancer, and more.

Please enable Javascript to view this content

As DiGiusto points out, these efforts have the possibility to “end great suffering if ultimately successfully commercialized.”

While there are other laboratories around the U.S. working on projects like cell-based approaches to cancer, what is impressive about Stanford’s efforts is the massive scale. A bit like legendary research facilities such as Xerox PARC — where much of the technology behind the personal computer revolution was invented — there are so many interesting projects being carried out at the Laboratory for Cell and Gene Medicine that it’s difficult to name them all.

Suffice it to say that if you hadn’t heard of the lab before now, that will almost certainly change over the coming years.

“There are now quite a few academic manufacturing facilities supporting [similar] efforts but most are working on only two or three products,” DiGiusto said. “Stanford has a broad portfolio of candidate cell and gene therapies that we will likely have eight to 10 products in the queue at all times. Because Stanford has the basic science, translational, and manufacturing capability, and 2 hospitals focused on clinical research — Stanford Health Care and Lucile Packard Children’s Hospital — we have a tremendous infrastructure in place to develop and test a wide array of candidate therapies. The magnitude of the effort is quite significant.”

Luke Dormehl
Former Digital Trends Contributor
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Hyundai Ioniq 5 sets world record for greatest altitude change
hyundai ioniq 5 world record altitude change mk02 detail kv

When the Guinness World Records (GWR) book was launched in 1955, the idea was to compile facts and figures that could finally settle often endless arguments in the U.K.’s many pubs.

It quickly evolved into a yearly compilation of world records, big and small, including last year's largest grilled cheese sandwich in the world.

Read more
Global EV sales expected to rise 30% in 2025, S&P Global says
ev sales up 30 percent 2025 byd sealion 7 1stbanner l

While trade wars, tariffs, and wavering subsidies are very much in the cards for the auto industry in 2025, global sales of electric vehicles (EVs) are still expected to rise substantially next year, according to S&P Global Mobility.

"2025 is shaping up to be ultra-challenging for the auto industry, as key regional demand factors limit demand potential and the new U.S. administration adds fresh uncertainty from day one," says Colin Couchman, executive director of global light vehicle forecasting for S&P Global Mobility.

Read more
Faraday Future could unveil lowest-priced EV yet at CES 2025
Faraday Future FF 91

Given existing tariffs and what’s in store from the Trump administration, you’d be forgiven for thinking the global race toward lower electric vehicle (EV) prices will not reach U.S. shores in 2025.

After all, Chinese manufacturers, who sell the least expensive EVs globally, have shelved plans to enter the U.S. market after 100% tariffs were imposed on China-made EVs in September.

Read more